This study conducted by the UOC aims to find out the opinion of the Spanish population and professional healthcare personnel on the COVID-19 vaccines
Description of Study:
- Title: Social perception study of COVID-19 vaccines.
- Principal Investigador: Francesc Saigí.
- Co-Investigators: Salvador Macip, Marina Bosque and Hans Eguia.
- Design: Participants will complete an online survey that will provide insight into societal perceptions of vaccines and, based on the results, will allow the development of strategic recommendations to improve vaccine uptake.
- Methods: Data will be collected through a very short online survey that takes one minute to complete. It will collect demographic data about the user and ask about their intention to be vaccinated.
Objectives of the Study:
Principal Objective: To find out the opinion of the Spanish population and professional healthcare personnel on the COVID-19 vaccines.
More about this Study:
Scientific Context: The development of vaccines for COVID-19 has been an unprecedented scientific milestone. But all sorts of controversies have surrounded it: from supply and organisational problems in the vaccination campaign to alarms created by the possible side effects of some of the vaccines. All this has created a climate of mistrust and infoxication. Against this backdrop, the Universitat Oberta de Catalunya (Open University of Catalonia, UOC) eHealth Center is promoting this study to find out what the Spanish population and professional healthcare staff think about the COVID-19 vaccines.
Added Value: This study will contribute to improving the population’s view of the COVID-19 vaccines and prevent infoxication from influencing their intention to be vaccinated.
eHealth Center: It is an academic centre open to the world whose goal is to educate and empower professionals and ordinary citizens, through the use of technologies, to lead the paradigm shift in health. It focuses on people, through research, education and guidance, to contribute to the progress and wellbeing of society.
Other UOC Studies: This is not the UOC’s first study on the perception of COVID-19 vaccines. It recently published the results of the study « Spain’s Hesitation at the Gates of a COVID-19 Vaccine » in the journal Vaccines, a study which assessed the intention of health professionals to be vaccinated and which showed that almost eight out of ten are willing to be inoculated with the COVID-19 vaccine.
Et si les chiens étaient capables de détecter les personnes positives au Covid-19? C’est la question à laquelle tente de répondre dans cette étude le Pr Dominique Grandjean, enseignant-chercheur de l’EnvA à l’initiative du projet Nosaïs-Covid19.
L’objectif de ce projet novateur, dirigé pour le Bataillon des Marins Pompiers de Marseille, est d’analitzer les eaux usées et valider les protocoles de désinfection sur des sites exposés au virus à Marseille.
The CoronaSurveys project is a collaborative endeavour between several universities, research institutions and independent volunteers that aims to collect and publish data related to the COVID-19 pandemic in different countries.
Chest Computed Tomography (CT) + Artificial Intelligence (AI): a potential complementary approach to RT-PCR for COVID-19 detection and lesion characterization.
An ultrasound severity index has been created to demonstrate the effectiveness of portable lung ultrasound both for diagnosis and for daily monitoring of patients with COVID-19 pneumonia.
This cross-sectional study aims to determine the attitude of the Spanish population towards vaccination against COVID-19.
A study that presents a method to mitigate the epidemic effects by estimating the number of COVID-19 cases without having to wait for laboratory confirmations.
This study, the first one of the +AGIL-COVID19 program, assesses the effect of the lockdown due to the COVID-19 on physical activity levels and emotional wellbeing on frail older adults.
A study to determine if influenza vaccination or ACEI or ARB medication has effects on COVID-19.
The Col-VID study aims to determine whether the use of colchicine reduces the severity or even prevents death in patients with COVID-19.